Invitris vs. Ginkgo Bioworks: Cell-Free Synthesis vs. Cell Programming
Compare the efficiency of patent-pending cell-free protein production against industrial-scale organism design.
Written by Hustlin from public information. Invitris hasn’t joined Hustlin.
Invitris and Ginkgo Bioworks represent two different approaches to synthetic biology. Invitris focuses on a cell-free platform that turns DNA into synthetic proteins and bacteriophages with massive efficiency gains. Ginkgo Bioworks operates as a horizontal foundry, engineering living organisms for a wide range of industrial and pharmaceutical applications.
Where Invitris is strong
- 10,000x more efficient protein production compared to traditional methods
- Material costs are reduced by more than 100x
- Specialized platform for creating synthetic bacteriophages to fight antibiotic resistance
- Technology validated by a feature in Science magazine
- Patent-pending platform that radically simplifies drug creation
Where Ginkgo Bioworks is strong
- Massive horizontal infrastructure with large-scale foundry capabilities
- Extensive experience in complex metabolic engineering and organism design
- Broad ecosystem of partners across agriculture, food, and pharma
Side-by-side comparison
| Category | Invitris | Ginkgo Bioworks | Edge |
|---|---|---|---|
| Core Technology | Cell-free synthesis | Cell programming | Neck-and-neck |
| Production Speed | >10,000x more efficient | Standard cell growth cycles | Stronger |
| Material Cost | <100x lower costs | Industrial scale overhead | Stronger |
| Primary Output | Synthetic proteins & phages | Engineered living organisms | Neck-and-neck |
| Scientific Validation | Science magazine feature | Extensive public track record | Neck-and-neck |
| Main Use Case | Novel biological drugs | Industrial bio-manufacturing | Neck-and-neck |
Which one should you pick?
Choose Invitris if you need to rapidly prototype synthetic proteins or develop bacteriophages for antibiotic-resistant infections at a fraction of the traditional cost and time.
Choose Ginkgo Bioworks if your project requires the large-scale engineering of living cells for industrial fermentation or complex agricultural applications.
Frequently asked questions
Is Invitris better than Ginkgo Bioworks?
It depends on your goal. Invitris is optimized for rapid, low-cost protein and phage synthesis without living cells, while Ginkgo is built for large-scale organism design.
How is Invitris different from Ginkgo?
Invitris uses a cell-free platform to turn DNA directly into proteins, whereas Ginkgo programs living cells to produce desired outputs.
When should I use Invitris over Ginkgo?
Use Invitris when speed and material cost are critical, specifically for drug discovery and synthetic bacteriophage development.
Can Ginkgo Bioworks produce bacteriophages?
Ginkgo can engineer organisms to produce various biologicals, but Invitris has a specialized, patent-pending platform specifically for synthetic bacteriophages.
Is Invitris's technology scientifically proven?
Yes, Invitris's technology was recently featured in Science magazine and is currently patent-pending.
Try Invitris
Get started with InvitrisBuilding something?
Create a free Hustlin account. Your first Ship Day includes a campus invite, a blog post, and social posts with real URLs.
Create your free account